Second-Trimester Maternal Serum Paraxanthine, CYP1A2 Activity, and the Risk of Severe Preeclampsia

Eichelberger, Kacey Y.; Baker, Arthur M.; Woodham, Padmashree C.; More

Obstetrics & Gynecology . 126(4):725-730, October 2015.

Diabetes Screening Reminder for Women With Prior Gestational Diabetes: A Randomized Controlled Trial

Zera, Chloe A.; Bates, David W.; Stuebe, Alison M.; More

Obstetrics & Gynecology . 126(1):109-114, July 2015.

Buprenorphine and Naloxone Compared With Methadone Treatment in Pregnancy

Wiegand, Samantha L.; Stringer, Elizabeth M.; Stuebe, Alison M.; More

Obstetrics & Gynecology . 125(2):363-368, February 2015.

Cost Analysis of Maternal Disease Associated With Suboptimal Breastfeeding

Bartick, Melissa C.; Stuebe, Alison M.; Schwarz, Eleanor Bimla; More

Obstetrics & Gynecology . 122(1):111-119, July 2013.

Reevaluation of Discriminatory and Threshold Levels for Serum β-hCG in Early Pregnancy

Connolly, AnnaMarie; Ryan, David H.; Stuebe, Alison M.; More

Obstetrics & Gynecology . 121(1):65-70, January 2013.

  • Journal Club

Gestational Glucose Tolerance and Maternal Metabolic Profile at 3 Years Postpartum

Stuebe, Alison M.; Mantzoros, Christos; Kleinman, Ken; More

Obstetrics & Gynecology . 118(5):1065-1073, November 2011.

Duration of Lactation and Risk Factors for Maternal Cardiovascular Disease

Schwarz, Eleanor Bimla; Ray, Roberta M.; Stuebe, Alison M.; More

Obstetrics & Gynecology . 113(5):974-982, May 2009.

  • Annual Awards